Bioheart, Inc.
13794 NW 4th Street, Suite 212
Sunrise, Florida 33325
Telephone: (954)-835-1500
Fax: (954)-845-9976
bioheart@bioheartinc.com
Latest News
Bioheart Launches new website Welcome to our newly designed website. Latest news coming soon! More Info >
Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd
SUNRISE, Fla., Sept. 10 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT - News) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today More Info >
Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry
United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients
Bioheart is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic, acute heart damage, and peripheral vascular disease
Latest News Release
Bioheart Elects Lee Jones to Its Board of Directors
Recovery of Damaged Heart Possible Through Stem Cells Therapy
Positive Results in the MARVEL Phase II/ III Clinical Trial
Bioheart Makes Breakthrough in Cardiovascular Therapy with Stem Cells Obtained from Fat Tissue
Scientific Panel Discussion
Live Webcast - Thursday, June 4, 2009.
Listen to Webcast Audio
Shareholder Update
Latest SEC Filing: 8-K Current Report, December 1, 2009
Bioheart, Inc 10Q, November 13, 2009